Publicacions - Fundació Institut d'Investigació en Ciències de la

IF: 3,268
Cañadas MP, Darwich L, Sirera G, Cirigliano V, Bofill M, Clotet B, Videla S; on behalf of the HIV-HPV Study
Group.
New molecular method for the detection of human papillomavirus type 16 integration.
CLIN MICROBIOL INFEC 2010 Jul;16(7):836-42
IF: 4,784
Caro-Murillo AM, Gil Luciano A, Navarro Rubio G, Leal Noval M, Blanco Ramos JR; Cohorte de la Red de
Investigación en Sida (CoRIS). (in collaborators Clotet B, Tural C, Ruiz L, Muga R, Tor J, Sanvisens A,
Blanco J)
[HIV infection in different age groups: Potential implications for prevention. CoRIS Cohort, Spain, 2004-
2008].
MED CLIN-BARCELONA 2010 Apr 24;134(12):521-7. Epub 2010 Mar 6.
IF: 1,413
Echeverría P, Negredo E, Carosi G, Gálvez J, Gómez JL, Ocampo A, Portilla J, Prieto A, López JC, Rubio R,
Mariño A, Pedrol E, Viladés C, del Arco A, Moreno A, Bravo I, López-Blazquez R, Pérez-Alvarez N, Clotet
B.
Similar antiviral efficacy and tolerability between efavirenz and lopinavir/ritonavir, administered with
abacavir/lamivudine (Kivexa), in antiretroviral-naïve patients: a 48-week, multicentre, randomized study
(Lake Study)
ANTIVIR RES 2010 Feb;85(2):403-8. Epub 2009 Nov 24.
IF: 4,439
Ferreira MA, Mangino M, Brumme CJ, Zhao ZZ, Medland SE, Wright MJ, Nyholt DR, Gordon S, Campbell
M, McEvoyBP, Henders A, Evans DM, Lanchbury JS, Pereyra F; International HIV Controllers Study,
Walker BD, Haas DW, Soranzo N, Spector TD, de Bakker PI, Frazer IH, Montgomery GW, Martin NG.
(Llibre JM in collaborators)
Quantitative trait loci for CD4:CD8 lymphocyte ratio are associated with risk of type 1 diabetes and HIV-
1 immune control.
AM J HUM GENET 2010 Jan;86(1):88-92. Epub 2009 Dec 31.
IF: 11,68
Ghosn J, Flandre P, Cohen-Codar I, Girard PM, Chaix ML, Raffi F, Dellamonica P, Ngovan P, Norton M,
Delfraissy JF;MONARK Study Group. (Llibre JM)
Long-term (96-week) follow-up of antiretroviral-naïve HIV-infected patients treated with first-line
lopinavir/ritonavir monotherapy in the MONARK trial.
HIV MED 2010 Feb;11(2):137-42. Epub 2009 Aug 13.
IF: 3,575
International HIV Controllers Study, Pereyra F, Jia X, McLaren PJ, Telenti A, de Bakker PI, Walker BD,
Ripke S, Brumme CJ, Pulit SL, Carrington M, Kadie CM, Carlson JM, Heckerman D, Graham RR, Plenge
RM, Deeks SG, Gianniny L, Crawford G, Sullivan J, Gonzalez E, Davies L, Camargo A, Moore JM, Beattie N,
Gupta S, Crenshaw A, Burtt NP, Guiducci C, Gupta N, Gao X, Qi Y, Yuki Y, Piechocka-Trocha A, Cutrell E,
Rosenberg R, Moss KL, Lemay P, O'Leary J, Schaefer T, Verma P, Toth I, Block B, Baker B, Rothchild A,
Lian J, Proudfoot J, Alvino DM, Vine S, Addo MM, Allen TM, Altfeld M, Henn MR, Le Gall S, Streeck H,
Haas DW, Kuritzkes DR, Robbins GK, Shafer RW, Gulick RM, Shikuma CM, Haubrich R, Riddler S, Sax PE,
Daar ES, Ribaudo HJ, Agan B, Agarwal S, Ahern RL, Allen BL, Altidor S, Altschuler EL, Ambardar S, Anastos
K, Anderson B, Anderson V, Andrady U, Antoniskis D, Bangsberg D, Barbaro D, Barrie W, Bartczak J,
Barton S, Basden P, Basgoz N, Bazner S, Bellos NC, Benson AM, Berger J, Bernard NF, Bernard AM, Birch
Pàgina 90 de 148